ArticleJournal of diabetes investigation2026

Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal.

Salvatore CorraoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.